Last Updated: November 8, 2026
Quick Summary
People with a personal or family history of medullary thyroid carcinoma or MEN2 should generally not take GLP-1 medications. Other conditions, such as pancreatitis, severe gastroparesis, pregnancy, and breastfeeding, call for caution or a clinician review before starting.
- A personal or family history of medullary thyroid carcinoma or MEN2 is usually a clear reason not to start.
- History of pancreatitis or severe gastroparesis requires a clinician review, since the drugs slow stomach emptying.
- GLP-1 medications are generally not recommended during pregnancy, and stopping is advised once pregnancy is planned or confirmed.
- Bring a complete medication list, including supplements, to your screening so interactions can be checked.
- Do not stop or restart a GLP-1 medication on your own without medical advice.
Table of Contents
- Why Some People Should Not Take GLP-1 Medications
- GLP-1 Medication Contraindications: Absolute Versus Caution
- GLP-1 Drug Interactions List: Medications and Conditions to Review
- Pregnancy, Trying to Conceive, and Breastfeeding
- GLP-1 Long-Term Side Effects and Monitoring
- Are GLP-1 Medications Safe Long-Term? What the Evidence Shows
- Next Step: Scheduling a Medical Screening Before You Start
- Frequently Asked Questions
Why Some People Should Not Take GLP-1 Medications
Most people who ask about GLP-1 medications want to know one thing: is this safe for me? The honest answer is that these drugs are not right for everyone, and a clinician needs to check your history before you start. Gallup’s 2026 national data shows that 66% of current GLP-1 users took a brand-name version, while 13% were unsure which type they took Gallup 2026 report on U.S. GLP-1 usage. That gap matters, because knowing exactly what you are taking is part of staying safe.

!A middle-aged woman and a clinician review a printed medical history form together in a bright exam room
Share of GLP-1 users by product type in 2026
GLP-1 Medication Contraindications: Absolute Versus Caution
A contraindication is a condition that makes a medication unsafe to use. A caution is a condition that calls for closer monitoring or a careful risk discussion. Knowing the difference helps you ask better questions, because the two categories lead to very different decisions: one usually means the drug is off the table, the other means the prescriber needs more information before proceeding.
Clinicians often find it useful to sort risk into three buckets rather than a simple yes-or-no list. Formal contraindications are conditions where the prescribing information says the drug should not be used. Precautions are conditions that warrant monitoring, dose adjustment, or a slower titration. Individualized-assessment factors are things like age, frailty, or nutritional status that do not rule out treatment but change the benefit-risk conversation. Keeping these separate reduces the confusion caused by broad claims that a single condition automatically rules out every GLP-1 medication.
Personal or Family History of Medullary Thyroid Carcinoma and MEN2
Medullary thyroid carcinoma (MTC) is a rare thyroid cancer that arises from the thyroid’s C cells. Multiple endocrine neoplasia type 2 (MEN2) is an inherited syndrome that carries a high lifetime risk of MTC. Human data have not confirmed the same risk, but the warning is treated as class-wide because the signal cannot be ruled out. Compare the side effects of tirzepatide and semaglutide in a clinical comparison.
This is one of the few areas where the answer is usually a clear no rather than a maybe. If you have a personal or family history of MTC or MEN2, raise it before any GLP-1 is prescribed. Many people do not know this history until they are asked directly, so it is worth calling a relative to check before your appointment.
History of Pancreatitis and Severe Gastroparesis
A history of pancreatitis raises concern about these medications, and the labeling for several GLP-1 products lists a history of pancreatitis as a precaution or contraindication depending on the product.
Severe gastroparesis, where the stomach empties too slowly, is a more direct concern because GLP-1 medications slow gastric emptying by design. For someone with severe gastroparesis, that mechanism can turn a manageable condition into persistent vomiting, dehydration, or malnutrition. Milder gastrointestinal conditions usually call for a slower dose escalation rather than avoidance.
Watch out: severe stomach pain, persistent vomiting, or pain that spreads to the back should be reported to a clinician right away rather than managed at home, because those symptoms can signal pancreatitis or a bowel problem that needs urgent evaluation.
Medication-Specific Warnings Versus Class-Wide Cautions
One of the most common sources of confusion is that the warnings are not identical across products. Some GLP-1 medications carry a boxed warning for thyroid C-cell tumors; others do not, and the prescribing information for each product is the authoritative source for that product’s contraindications. A few products also carry specific warnings related to diabetic retinopathy complications, gallbladder disease, or pulmonary aspiration during anesthesia, and those warnings may differ by formulation and by whether the drug is approved for diabetes or for weight management.
That is why ‘can I take a GLP-1?’ is the wrong question. The better question is ‘which GLP-1, at what dose, for what indication, given my specific history?’ A clinician who reviews the actual prescribing information for the specific product, rather than relying on a class-wide summary, is doing the job correctly.
What to Do If You Have a Contraindication or Warning
If you recognize yourself in any of the categories above, the next step is not to stop or start a medication on your own. Contact the prescriber who manages your GLP-1 therapy, or the clinician who would prescribe it, and describe the specific condition, when it was diagnosed, and any family history you have confirmed.
Do not stop a GLP-1 medication abruptly without medical advice, and do not restart one after a gap without checking in, because dose timing and titration matter. If you have not started treatment yet, a screening visit is the right setting to sort formal contraindications from precautions and from factors that simply call for a more careful plan.
The article sorts GLP-1 risk into a few categories, summarised below so you can see which conditions are formal contraindications and which call for caution.
| Condition | Category | What it means |
|---|---|---|
| Personal or family history of MTC or MEN2 | Formal contraindication | Usually a clear no; raise before any prescription |
| History of pancreatitis | Precaution or contraindication | Depends on the product’s labeling |
| Severe gastroparesis | Direct concern | Slowed stomach emptying can cause persistent vomiting |
| Product-specific boxed warnings | Varies by product | Check the specific prescribing information |
GLP-1 Drug Interactions List: Medications and Conditions to Review
Some medications and health conditions can change how a GLP-1 drug affects you. Bring a complete list of everything you take, including supplements, to your appointment.
Key items to review include:
- Insulin or sulfonylureas, which can increase the risk of low blood sugar
- Oral medications that need steady absorption
- Alcohol use, which can worsen nausea and dehydration
- Kidney problems, which affect how fluids and medications clear the body
Pregnancy, Trying to Conceive, and Breastfeeding
Pregnancy and breastfeeding change the safety picture, and this is one area where the guidance is more practical than most people expect. GLP-1 medications are generally not recommended during pregnancy, and the labeling for most products advises stopping treatment when pregnancy is planned or confirmed. The reason is straightforward: these drugs slow gastric emptying and can reduce appetite and food intake, which matters for maternal nutrition and fetal growth, and human pregnancy data are limited.
Planning a Pregnancy While on a GLP-1
The timing question is the one most patients ask and most general articles skip. Because the different GLP-1 products clear the body at different rates, there is no single ‘stop X weeks before conception’ rule that applies to every medication.
That means the conversation should happen early, ideally months before you plan to conceive, not after a positive test. Bring your conception timeline to your prescriber and ask three questions: when should I stop this specific medication, what should I do about my blood sugar or weight plan in the meantime, and who will manage my care during pregnancy?
Watch out: stopping a GLP-1 abruptly without a plan can leave blood sugar poorly controlled in people with diabetes. Do not discontinue on your own; ask for a transition plan.
If Pregnancy Is Confirmed While Taking a GLP-1
If you become pregnant while taking a GLP-1 medication, contact your prescriber promptly rather than waiting for the next scheduled visit. Most guidance is to stop the medication once pregnancy is recognized, and the prescriber will want to review your obstetric care and any diabetes management. Do not restart the medication during pregnancy without explicit medical direction.
Breastfeeding
Breastfeeding is a separate question from pregnancy. The labeling for most GLP-1 products does not recommend use during breastfeeding, and the data on how much of the drug passes into breast milk are limited for this class. For someone who wants to breastfeed, the practical approach is to discuss timing with the prescriber: whether to delay restarting until breastfeeding is complete, or whether a different management plan makes sense in the interim. As with pregnancy, the answer depends on the specific product and the person’s overall health, so a general rule is less useful than a plan built around your situation.
Older Adults, Frailty, and Muscle Loss
Pregnancy is not the only life stage that changes the risk discussion. In older adults, especially those who are frail or already eating poorly, the appetite-suppressing effect of GLP-1 medications can contribute to inadequate protein and calorie intake and to loss of muscle mass. That does not automatically rule out treatment, but it does mean the benefit-risk conversation should include a nutrition plan, a strength or activity plan, and closer monitoring of weight and function. If you are an older adult considering a GLP-1, ask how your care team will track muscle mass and nutritional intake, not just weight.
GLP-1 Long-Term Side Effects and Monitoring
Common side effects include nausea, vomiting, diarrhea, and constipation. Most people notice these early in treatment. Serious side effects are less common, but they need prompt attention.
Regular check-ins with your care team help catch problems early. Ask what monitoring your plan includes, such as blood pressure, kidney function, and symptom tracking.
Are GLP-1 Medications Safe Long-Term? What the Evidence Shows
Research is still building. A Washington University School of Medicine study linked GLP-1 medications to lower risks of dementia and addiction, while also finding increased risks of kidney, pancreas, and gastrointestinal problems Washington University School of Medicine study on GLP-1 benefits and risks. The study summary does not give effect sizes, so treat these findings as a reason for ongoing monitoring, not a final verdict. Read the long-term effects evidence review for a fuller look at what the research shows so far.
A 2024 article in a PubMed Central journal advises caution with these drugs for people with a history of or risk for disordered eating, and recommends screening for it 2024 cautionary account on GLP-1 agonists and eating disorders. If that applies to you, say so openly with your clinician.
Next Step: Scheduling a Medical Screening Before You Start
Before you start any GLP-1 medication, book a medical screening. Bring your history, your medication list, and your questions. A physician-supervised program is the safest path, especially if you have a thyroid, pancreas, or pregnancy-related concern.
MedShape Weight Loss Clinics offers medically supervised programs, and a consultation with a qualified clinician is the way to discuss a plan for your health needs. You can explore our physician-led programs before you book, or compare a medical weight loss program with other options to see what fits your situation.
Frequently Asked Questions
Who should not take GLP-1 medications?
People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) are generally advised not to take GLP-1 receptor agonists, according to the prescribing information for these drugs. People with a history of pancreatitis, severe gastroparesis, or a history of disordered eating often need careful review or a different plan. Pregnancy and breastfeeding also call for a clinician’s guidance. Because individual risk depends on your full medical history, the only way to know whether these medications fit you is a screening with a qualified prescriber.
What conditions can make GLP-1 medications unsafe?
Conditions that call for avoidance or close caution include medullary thyroid carcinoma, MEN2, a history of pancreatitis, severe gastrointestinal disease such as gastroparesis, and active disordered eating. Kidney problems, dehydration risk, and some drug interactions also deserve review. A clinician can weigh these factors against your benefits and risks.
Are GLP-1 medications safe for long-term use?
Long-term safety is still being studied. Long-term use should involve regular monitoring and an ongoing review of your benefits and risks with your clinician.
Can GLP-1 medications interact with other prescriptions?
Yes, drug interactions are possible, and a complete medication list should be shared with your prescriber before starting treatment. Clinicians commonly review medicines that affect blood sugar, blood pressure, and digestion. Bring a list of all prescriptions, over-the-counter products, and supplements to your screening appointment so your clinician can check for potential interactions.